Magle Chemoswed Holding Ab (ST:MAGLE) — Market Cap & Net Worth
Market Cap & Net Worth: Magle Chemoswed Holding Ab (MAGLE)
Magle Chemoswed Holding Ab (ST:MAGLE) has a market capitalization of $1.12 Million (Skr10.43 Million) as of August 4, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #30495 globally and #714 in its home market, demonstrating a -51.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Magle Chemoswed Holding Ab's stock price Skr0.51 by its total outstanding shares 20649377 (20.65 Million). See Magle Chemoswed Holding Ab (MAGLE) capital reinvestment to understand how much of operating cash flow is reinvested back into capital assets.
Magle Chemoswed Holding Ab Market Cap History: 2020 to 2026
Magle Chemoswed Holding Ab's market capitalization history from 2020 to 2026. Data shows change from $102.11 Million to $1.12 Million (-45.39% CAGR).
Index Memberships
Magle Chemoswed Holding Ab is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.92 Billion | 0.01% | #242 of 281 |
Weight: Magle Chemoswed Holding Ab's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Magle Chemoswed Holding Ab Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Magle Chemoswed Holding Ab's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.14x
Magle Chemoswed Holding Ab's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $102.11 Million | $142.34 Million | $1.82 Million | 0.72x | 56.14x |
| 2021 | $66.44 Million | $132.15 Million | $4.28 Million | 0.50x | 15.53x |
| 2022 | $59.56 Million | $145.68 Million | $9.14 Million | 0.41x | 6.51x |
| 2023 | $56.00 Million | $170.44 Million | $12.17 Million | 0.33x | 4.60x |
| 2024 | $77.33 Million | $236.04 Million | $11.94 Million | 0.33x | 6.48x |
| 2025 | $39.11 Million | $282.92 Million | -$159.88 Million | 0.14x | N/A |
Competitor Companies of MAGLE by Market Capitalization
Companies near Magle Chemoswed Holding Ab in the global market cap rankings as of August 4, 2026.
Key companies related to Magle Chemoswed Holding Ab by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #222 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #423 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #541 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #564 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #222 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $470.72 |
| #423 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $759.24 |
| #541 | Argen-X | BR:ARGX | $49.55 Billion | €722.20 |
| #564 | UCB SA | BR:UCB | $47.34 Billion | €221.40 |
Magle Chemoswed Holding Ab Historical Marketcap From 2020 to 2026
Between 2020 and today, Magle Chemoswed Holding Ab's market cap moved from $102.11 Million to $ 1.12 Million, with a yearly change of -45.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr1.12 Million | -97.13% |
| 2025 | Skr39.11 Million | -49.43% |
| 2024 | Skr77.33 Million | +38.10% |
| 2023 | Skr56.00 Million | -5.97% |
| 2022 | Skr59.56 Million | -10.37% |
| 2021 | Skr66.44 Million | -34.93% |
| 2020 | Skr102.11 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of Magle Chemoswed Holding Ab was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.12 Million USD |
| MoneyControl | $1.12 Million USD |
| MarketWatch | $1.12 Million USD |
| marketcap.company | $1.12 Million USD |
| Reuters | $1.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Magle Chemoswed Holding Ab
Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride… Read more